Akbari B - Search Results

1

Evolution of phage display technology: from discovery to application.

Rahbarnia L, Farajnia S, Babaei H, Majidi J, Veisi K, Ahmadzadeh V, Akbari B. Rahbarnia L, et al. Among authors: akbari b. J Drug Target. 2017 Mar;25(3):216-224. doi: 10.1080/1061186X.2016.1258570. Epub 2016 Nov 21. J Drug Target. 2017. PMID: 27819143 Review.

2

Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR).

Ahdi Khosroshahi S, Farajnia S, Ghiamirad M, Tanomand A, Veisi K, Rahbarnia L, Akbari B. Ahdi Khosroshahi S, et al. Among authors: akbari b. Protein Expr Purif. 2016 Apr;120:59-64. doi: 10.1016/j.pep.2015.12.005. Epub 2015 Dec 12. Protein Expr Purif. 2016. PMID: 26690373

3

Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR).

Akbari B, Farajnia S, Zarghami N, Mahdieh N, Rahmati M, Khosroshahi SA, Rahbarnia L. Akbari B, et al. Protein Expr Purif. 2016 Nov;127:8-15. doi: 10.1016/j.pep.2016.06.001. Epub 2016 Jun 11. Protein Expr Purif. 2016. PMID: 27298212

4

Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology.

Rahbarnia L, Farajnia S, Babaei H, Majidi J, Veisi K, Tanomand A, Akbari B. Rahbarnia L, et al. Among authors: akbari b. Biologicals. 2016 Nov;44(6):567-573. doi: 10.1016/j.biologicals.2016.07.002. Epub 2016 Aug 9. Biologicals. 2016. PMID: 27520285

5

Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A.

Akbari B, Farajnia S, Zarghami N, Mahdieh N, Rahmati M, Khosroshahi SA, Barzegar A, Rahbarnia L. Akbari B, et al. Anticancer Drugs. 2017 Mar;28(3):263-270. doi: 10.1097/CAD.0000000000000452. Anticancer Drugs. 2017. PMID: 27861173

6

Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display Technology.

Rahbarnia L, Farajnia S, Babaei H, Majidi J, Akbari B, Ahdi Khosroshahi S. Rahbarnia L, et al. Among authors: akbari b. Adv Pharm Bull. 2016 Dec;6(4):563-571. doi: 10.15171/apb.2016.070. Epub 2016 Dec 22. Adv Pharm Bull. 2016. PMID: 28101463 Free PMC article.

7

Immunotoxins in cancer therapy: Review and update.

Akbari B, Farajnia S, Ahdi Khosroshahi S, Safari F, Yousefi M, Dariushnejad H, Rahbarnia L. Akbari B, et al. Int Rev Immunol. 2017 Jul 4;36(4):207-219. doi: 10.1080/08830185.2017.1284211. Epub 2017 Mar 1. Int Rev Immunol. 2017. PMID: 28282218 Review.

8

Soluble Expression of Humanized Anti-CD20 Single Chain Antibody in Escherichia coli by Cytoplasmic Chaperones Co-expression.

Yousefi M, Farajnia S, Mokhtarzadeh A, Akbari B, Ahdi Khosroshahi S, Mamipour M, Dariushnejad H, Ahmadzadeh V. Yousefi M, et al. Among authors: akbari b. Avicenna J Med Biotechnol. 2018 Jul-Sep;10(3):141-146. Avicenna J Med Biotechnol. 2018. PMID: 30090206 Free PMC article.

9

Expression and Evaluation of HuscFv Antibody -PE40 Immunotoxin for Target Therapy of EGFR-Overexpressing Cancers.

Falahatgar D, Farajnia S, Zarghami N, Tanomand A, Khosroshahi SA, Akbari B, Farajnia H. Falahatgar D, et al. Among authors: akbari b. Iran J Biotechnol. 2018 Dec 12;16(4):e1743. doi: 10.21859/ijb.1743. eCollection 2018 Dec. Iran J Biotechnol. 2018. PMID: 31457033 Free PMC article.

10

The interaction of phages and bacteria: the co-evolutionary arms race.

Safari F, Sharifi M, Farajnia S, Akbari B, Karimi Baba Ahmadi M, Negahdaripour M, Ghasemi Y. Safari F, et al. Among authors: akbari b. Crit Rev Biotechnol. 2020 Mar;40(2):119-137. doi: 10.1080/07388551.2019.1674774. Epub 2019 Dec 2. Crit Rev Biotechnol. 2020. PMID: 31793351 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page